methylformamide has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldini, N; Del Bufalo, D; Lollini, PL; Manara, MC; Maurici, D; Scotlandi, K; Serra, M | 1 |
| Viadro, MM | 1 |
2 other study(ies) available for methylformamide and Osteogenic Sarcoma
| Article | Year |
|---|---|
Pre-treatment of human osteosarcoma cells with N-methylformamide enhances P-glycoprotein expression and resistance to doxorubicin.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Carrier Proteins; Cell Differentiation; Cell Division; Doxorubicin; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Formamides; Humans; Membrane Glycoproteins; Osteosarcoma; Subcellular Fractions; Tumor Cells, Cultured; Verapamil | 1994 |
[Changes in lectin-induced agglutination of human tumor cells during the process of their reversion].
Topics: Acetamides; Agglutination; Concanavalin A; Culture Media; Dimethyl Sulfoxide; Dimethylformamide; Drug Interactions; Formamides; Humans; In Vitro Techniques; Osteosarcoma | 1985 |